Efficacy News and Research

RSS

Determining COVID-19 vaccine effectiveness among health care workers in Wales

A new study revealed an overall high vaccine uptake and significant vaccine effectiveness of BNT162b2 against COVID-19, among healthcare workers in Wales.

20 Jan 2022

Natural extracellular vesicles containing ACE2 protein could fight new SARS-CoV-2 variants

Scientists at The University of Texas MD Anderson Cancer Center and Northwestern Medicine have identified natural extracellular vesicles containing the ACE2 protein (evACE2) in the blood of COVID-19 patients that can block infection from broad strains of SARS-CoV-2 virus in preclinical studies. The study was published today in Nature Communications.

20 Jan 2022

Exploring the potential utility of calcium channel inhibitors in SARS-CoV-2 infection

In a new study, researchers discuss the role of calcium signaling pathways as targets of inhibition in potential new antiviral therapeutic pathways for SARS-CoV-2.

20 Jan 2022

The effect of different heterologous vaccination intervention strategies on the winter 2020 COVID-19 wave in the US

Researchers demonstrated the effect of different heterologous vaccine interventions on COVID-19 caseloads, hospitalization, and mortality in the US.

20 Jan 2022

Investigational cancer drug mimics the metabolic and therapeutic effects of fasting, mice study shows

An investigational cancer drug that starves tumors of their energy supply also shows evidence of improving whole body metabolism, according to a new study in mice from Washington University School of Medicine in St. Louis.

19 Jan 2022

Novel antibody that targets the N-terminal domain of SARS-CoV-2 identified

A new study discusses the targeted discovery of NTD-reactive antibodies from an individual who had recovered from SARS-CoV-2 infection.

19 Jan 2022

Non-invasive, novel urinary miRNA biomarker panel for colorectal cancer diagnosis

Researchers set out to develop and validate urine biomarkers for diagnosing gastric cancer and colorectal cancer.

19 Jan 2022

Independent drug action responsible for greater clinical efficacy of combination cancer therapies

Independent drug action, not synergy nor additivity, accounted for the clinical efficacy of nearly all examined combination therapies involving immune checkpoint inhibitors in clinical trials, according to results from a retrospective analysis.

19 Jan 2022

The latest advancements in polymer-based nanotechnology approaches used to fight against SARS-CoV-2

A recent review discusses the engineering versatility of polymeric nanoparticles - making a good therapeutic alternative against coronavirus diseases.

19 Jan 2022

Schoolchildren in Hong Kong surveyed on the prevalence and impact of allergic diseases

A collaborative study by the Department of Social Work and Social Administration, the University of Hong Kong andthe Department of Paediatrics and Adolescent Medicine, United Christian Hospital

19 Jan 2022

New method reverses insecticide resistance using CRISPR/Cas9 technology

Insecticides play a central role in efforts to counter global impacts of mosquito-spread malaria and other diseases, which cause an estimated 750,000 deaths each year. These insect-specific chemicals, which cost more than $100 million to develop and bring to market, also are critical to controlling insect-driven damage on crops that poses a challenge to food security.

18 Jan 2022

New perspective on SARS-CoV-2 breakthrough infections and booster shot restoration of vaccine efficacy

A recent article published in the journal Science explains how SARS-CoV-2 variants can bypass vaccine-induced immune defenses. However, immunity is restorable with a booster shot. The paper's authors outlined the importance of a booster shot in maintaining immunity and preventing severe infection.

18 Jan 2022

Study shows several low- and middle-income countries at over 50% risk of undetected Omicron transmission

In a new study, researchers estimated the probability of undetected emergence of the SARS-CoV-2 Omicron variant in 25 low and middle-income countries by early December 2021.

18 Jan 2022

Immune responses in Omicron breakthrough COVID-19

A recent study examined the question as to whether vaccination protects against Omicron infection by assessing breakthrough infection rates in participants at a superspreader event.

18 Jan 2022

Gaseous ozone is effective for SARS-CoV-2 disinfection

In their recent study published in the Journal of Hazardous Materials, researchers from the United Kingdom have found that ozone as a disinfectant is effective for the inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in liquid cell culture media as well as adhered on surfaces.

18 Jan 2022

Efficacy News and Research

Determining COVID-19 vaccine effectiveness among health care workers in Wales

Natural extracellular vesicles containing ACE2 protein could fight new SARS-CoV-2 variants

Exploring the potential utility of calcium channel inhibitors in SARS-CoV-2 infection

The effect of different heterologous vaccination intervention strategies on the winter 2020 COVID-19 wave in the US

Investigational cancer drug mimics the metabolic and therapeutic effects of fasting, mice study shows

Novel antibody that targets the N-terminal domain of SARS-CoV-2 identified

Non-invasive, novel urinary miRNA biomarker panel for colorectal cancer diagnosis

Independent drug action responsible for greater clinical efficacy of combination cancer therapies

The latest advancements in polymer-based nanotechnology approaches used to fight against SARS-CoV-2

Schoolchildren in Hong Kong surveyed on the prevalence and impact of allergic diseases

New method reverses insecticide resistance using CRISPR/Cas9 technology

New perspective on SARS-CoV-2 breakthrough infections and booster shot restoration of vaccine efficacy

Study shows several low- and middle-income countries at over 50% risk of undetected Omicron transmission

Immune responses in Omicron breakthrough COVID-19

Gaseous ozone is effective for SARS-CoV-2 disinfection

Evidence that monoclonal antibodies can reduce COVID-19 (Delta) mortality

Effects of post-acute COVID-19 on physical and mental health in women

Meta-analysis confirms complete failure of hydroxychloroquine/chloroquine as a COVID-19 treatment

Quantification of SARS-CoV-2 variants in wastewater samples

Efficacy and safety of mRNA-based SARS-CoV-2 vaccination in immuno-compromised subjects

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News